Possible colchicine rhabdomyolysis in a fluvastatin-treated patient - Enes Murat Atasoyu, T Rifki
Evrenkaya, Emrullah Solmazgul, 2005 Skip to main content Intended for healthcare professionals …

Background Rhabdomyolysis is a widely recognized yet rare complication in statin use.
Rhabdomyolysis might be triggered by the prescription of high doses of statins or by statin …

A case of fluvastatin-induced rhabdomyolysis after coadministration of colchicine is reported.
A 77 year old man with ischemic heart disease, chronic pericardial effusion, diabetes …

OBJECTIVE: To report a case of rhabdomyolysis resulting from concurrent use of
cerivastatin and gemfibrozil. CASE SUMMARY: An 82-year-old white man presented to the …

Cerivastatin is the new 3rd-generation of the synthetic 3-hydroxy-3-methylglutaryl-coenzyme
A (HMG-CoA) reductase inhibitors, the 1st drugs of choice for treating hypercholesterolemia …

Rhabdomyolysis is a rare but life-threatening complication of statin therapy. A 74-year-old
man, treated with atorvastatin, developed rhabdomyolysis after the co-administration of …

OBJECTIVE: Presentation of a case of lovastatin-induced rhabdomyolysis in the absence of
other medications known to potentiate this adverse effect. METHODOLOGY: Case report …

Lovastatin-induced acute rhabdomyolysis Page 1 Postgrad Med J (1990) 66, 294 - 296 ©)
The Fellowship of Postgraduate Medicine, 1990 Medicine in the Elderly Lovastatin-induced …

Rhabdomyolysis is an uncommon complication associated with 3‐hydroxy‐3‐methylglutaryl
coenzyme A reductase inhibitors. We observed six cases of cerivastatin‐associated …

All available 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors
(“statins”) have been implicated in causing rhabdomyolysis, either as monotherapy or in …